Aleva Neurotherapeutics
Records under this name other than the patents Aleva Neurotherapeutics holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 10 patents it holds.
Showing 1 to 7 of 7 · Back to Aleva Neurotherapeutics
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,925,376 | Treatment of autoimmune diseases with deep brain stimulation Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,201,707 | Treatment of autoimmune diseases with deep brain stimulation Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,344,728 | Neurostimulation device with recording patch Lapsed on the fee record Ended May 31, 2026 · USPTO record | Lapsed on the fee record | Ended May 31, 2026 | USPTO record |
| US 11,311,718 | Device for interacting with neurological tissue and methods of making and using the same Lapsed on the fee record Ended Apr 26, 2026 · USPTO record | Lapsed on the fee record | Ended Apr 26, 2026 | USPTO record |
| US 11,266,830 | Neurostimulation device Lapsed on the fee record Ended Mar 8, 2026 · USPTO record | Lapsed on the fee record | Ended Mar 8, 2026 | USPTO record |
| US 9,889,304 | Leadless neurostimulator Lapsed on the fee record Ended Feb 13, 2026 · USPTO record | Lapsed on the fee record | Ended Feb 13, 2026 | USPTO record |
| US 9,572,985 | Method of manufacturing a thin film leadless neurostimulator Lapsed on the fee record Ended Feb 21, 2025 · USPTO record | Lapsed on the fee record | Ended Feb 21, 2025 | USPTO record |